Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.
Τίτλος | Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome. |
Publication Type | Journal Article |
Year of Publication | 2012 |
Authors | Koiou, E., Tziomalos K., Dinas K., Katsikis I., Kandaraki E. A., Tsourdi E., Mavridis S., & Panidis D. |
Journal | Endocr J |
Volume | 59 |
Issue | 1 |
Pagination | 21-9 |
Date Published | 2012 |
ISSN | 1348-4540 |
Λέξεις κλειδιά | Adiposity, Adult, Anovulation, Biological Markers, Body Mass Index, Cohort Studies, Female, Humans, Hyperandrogenism, Insulin Resistance, Obesity, Overweight, Phenotype, Plasminogen Activator Inhibitor 1, Polycystic Ovary Syndrome, Practice Guidelines as Topic, Young Adult |
Abstract | We aimed to evaluate plasma plasminogen activator inhibitor-1 (PAI-1) antigen levels in women with polycystic ovary syndrome (PCOS) and different levels of adiposity and PCOS phenotypes. We studied 199 women with PCOS and 50 age-matched healthy women divided in normal weight (n=100 and n=25, respectively) and overweight/obese (n=99 and n=25, respectively). Normal weight and overweight/obese patients with PCOS were further divided in patients diagnosed according to the 1990 criteria (i.e. with anovulation and hyperandrogenemia; 1990 criteria group) and in patients with the additional phenotypes introduced in 2003 (i.e. with polycystic ovaries and either anovulation or hyperandrogenemia; additional 2003 criteria group). In normal weight subjects, plasma PAI-1 levels did not differ between women with PCOS (regardless of group) and controls, or between the 1990 criteria and the additional 2003 criteria groups of PCOS. In overweight/obese subjects, plasma PAI-1 levels were higher in both the 1990 criteria and the additional 2003 criteria groups of PCOS compared with controls (p<0.001 and p=0.004, respectively), but did not differ between the 1990 criteria and the additional 2003 criteria groups of PCOS. In conclusion, plasma PAI-1 levels are elevated in overweight/obese women with PCOS but not in normal weight women with this syndrome. Plasma PAI-1 levels do not differ between the phenotypes of PCOS. |
Alternate Journal | Endocr. J. |
PubMed ID | 21996594 |